S&P ASX All Technology

3,966.40

0.06%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TNG Transgene SA

0.714

-0.019 (-2.59%)

03 Dec 2024 - Closed

Delayed by 15 minutes

2024 Half-Year Financial Report

2024 Half Year Financial Report

Attachment

TRANSGENE_HALF-YEAR-FINANCIAL-REPORT-2024_EN

Transgene (EU:TNG)
Historical Stock Chart
From Nov 2024 to Dec 2024

Transgene (EU:TNG)
Historical Stock Chart
From Dec 2023 to Dec 2024

News

Transgene Reports Business, Pipeline and Financial Update for Q3 2024
Friday 8 November 2024 (4 weeks ago) • UK Regulatory

Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024
Friday 8 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Transgene et NEC présentent de nouvelles données confirmant la preuve de principe clinique pour son vaccin thérapeutique TG4050, dans les cancers de la tête et du cou au SITC 2024
Friday 8 November 2024 (4 weeks ago) • UK Regulatory

Transgene fait le point sur ses activités, son portefeuille et sa situation financière au troisième trimestre 2024
Friday 8 November 2024 (4 weeks ago) • UK Regulatory

Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development
Tuesday 5 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés
Tuesday 5 November 2024 (4 weeks ago) • UK Regulatory

Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development
Tuesday 5 November 2024 (4 weeks ago) • UK Regulatory

Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers
Monday 14 October 2024 (2 months ago) • GlobeNewswire Inc.

Transgene fait le point sur l’étude de Phase II du vaccin thérapeutique TG4001 dans les cancers du col de l’utérus et anogénitaux HPV16 positifs, récurrents ou métastatiques
Monday 14 October 2024 (2 months ago) • UK Regulatory

Transgene to Present a Poster on Updated Data for TG4050 at SITC 2024
Monday 7 October 2024 (2 months ago) • UK Regulatory

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

TNG Transgene SA

News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

TNG Transgene SA

News

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%